<ѻý>Are Federal Agencies Coming for Ketamine Clinics?ѻý> Compliance plans can help in the face of possible regulatory scrutiny Apr 01, 2024
<ѻý>Here's What OTC Continuous Glucose Monitors Can Do for Our Patientsѻý> FDA's approval may be a step toward greater access Mar 30, 2024
<ѻý>Sotatercept's FDA Approval a New Chapter for Pulmonary Arterial Hypertensionѻý> Biologic should arrive on pharmacy shelves before May Mar 27, 2024
<ѻý>FDA Questioned on Elon Musk's Neuralink; OTC Pain Relief Warning; Easter Egg Safetyѻý> Health news and commentary from around the Web gathered by ѻý staff Mar 27, 2024
<ѻý>Overdosing on Chemo: A Common Gene Test Could Save Hundreds of Lives Each Yearѻý> Treatment can be deadly for enzyme-deficient patients; NCCN doesn't call for preemptive testing Mar 26, 2024
<ѻý>FDA Again Tries to Ban 'Aversive' Shock Treatmentѻý> Agency proposed a new ban to eliminate shock therapy for self-injurious or aggressive behavior Mar 25, 2024
<ѻý>More Medication Prescribed for Self-Managed Abortion After Roe Fellѻý> While in-clinic abortions fell, many found other ways to access care Mar 25, 2024
<ѻý>SCOTUS Again Takes on Issue of Abortion, This Time Over Mifepristone Accessѻý> Law professor says the case has the potential to upend how drug approvals function Mar 25, 2024
<ѻý>Fixed-Dose Macitentan/Tadalafil Combo Gets FDA Approval for PAHѻý> Opsynvi puts two drugs commonly prescribed for pulmonary arterial hypertension into one tablet Mar 25, 2024
<ѻý>FDA Settles Ivermectin Case; When AI Makes a Medical Error; $97,000 Air Ambulanceѻý> Health news and commentary from around the Web gathered by ѻý staff Mar 25, 2024
<ѻý>New Monoclonal Authorized to Prevent COVID in Immunocompromised Peopleѻý> No such option has been available since FDA revoked the authorization of Evusheld last year Mar 22, 2024
<ѻý>Novel Drug Approved for All Duchenne Muscular Dystrophy Variantsѻý> Givinostat is the first nonsteroidal drug approved for DMD regardless of genetic mutation Mar 22, 2024
<ѻý>Expanded Label Officially Makes Bempedoic Acid a CVD Prevention Medicationѻý> New indications supported by CLEAR Outcomes trial Mar 22, 2024
<ѻý>FDA Approves New Frontline Regimen for Aggressive ALLѻý> Ponatinib lands indication in combination with chemo for Philadelphia chromosome-positive cases Mar 22, 2024
<ѻý>Graphic Images on Cigarettes of Smoking's Harm Are Constitutional, Court Rulesѻý> Partial victory for federal regulators seeking to toughen warning labels Mar 22, 2024
<ѻý>House Committee Wrestles With Lab Test Regulationѻý> Some favor a proposed FDA rule, while others push for passage of the VALID Act Mar 21, 2024
<ѻý>GOP Lawmakers Blast HHS, Biden for Plans to Loosen Marijuana Restrictionsѻý> Opposition to Medicaid work requirements also came on the table at a House hearing Mar 21, 2024
<ѻý>Wider Pool of Impella Heart Pumps Caught in Recall After 49 Deathsѻý> Devices require label correction for left ventricle perforation risk Mar 21, 2024
<ѻý>Novel Oral Antihypertensive Gets FDA's Blessingѻý> Aprocitentan becomes the first endothelin receptor antagonist for BP lowering Mar 20, 2024
<ѻý>Kate Middleton's Medical Records; FDA Syringe Warning; NIH Ends COVID Guidelinesѻý> Health news and commentary from around the Web gathered by ѻý staff Mar 20, 2024
<ѻý>Pediatric Neuron Disease Gets Its First Gene Therapyѻý> FDA approves arsa-cel for metachromatic leukodystrophy Mar 18, 2024
<ѻý>First Treatment Approved for Chronic Rhinosinusitis Without Nasal Polypsѻý> Daily sprays of Xhance reduced acute exacerbations by 56% to 66% in trials Mar 18, 2024
<ѻý>FDA Panel Gives Thumbs Up to Earlier Use of CAR T-Cell Therapy in Multiple Myelomaѻý> Cilta-cel, ide-cel win support despite concerns about early mortality risk Mar 16, 2024
<ѻý>FDA Approves First CAR-T for Chronic Lymphocytic Leukemiaѻý> Lisocabtagene maraleucel (Breyanzi) nabs new indication for relapsed or refractory CLL/SLL Mar 15, 2024
<ѻý>FDA Tries to Close the Lid on Poop Transplant Companyѻý> Fecal microbiota transplant business needs a BLA or IND to operate, agency says Mar 15, 2024
<ѻý>New PD-1 Inhibitor Approved for Esophageal Cancerѻý> Tislelizumab improved median OS from 6.3 months with chemotherapy to 8.6 months Mar 15, 2024
<ѻý>FDA Approves First-Ever Drug for Serious Liver Conditionѻý> Resmetirom indicated for NASH patients with liver scarring Mar 14, 2024
<ѻý>FDA Panel Endorses Imetelstat for MDS-Related Anemiaѻý> By 12-2 vote, members find improvement in transfusion independence outweighs risk Mar 14, 2024
<ѻý>Early Death Risk Muddies Risk-Benefit Assessment of CAR-T Therapies for Myelomaѻý> FDA advisory panel to weigh the evidence for cilta-cel, ide-cel in day-long meeting Mar 14, 2024
<ѻý>Don't Drive on These Meds; Darryl Strawberry's Heart Attack; CDC Airport Screeningѻý> Health news and commentary from around the Web gathered by ѻý staff Mar 13, 2024
<ѻý>FDA Staff Cast Doubt on Novel Drug for MDS-Related Anemiaѻý> Agency asking its advisors if benefits outweigh risks for patients who fail on standard treatment Mar 12, 2024
<ѻý>Banning Gain-of-Function Research Would Do Far More Harm Than Goodѻý> A House-passed bill could stifle the potential for revolutionary medical advancements Mar 11, 2024
<ѻý>Benzene Can Form in Acne Treatments, Lab Findsѻý> Benzoyl peroxide formulations can break down into the carcinogen Mar 07, 2024
<ѻý>First-Line Nivolumab Plus Chemo Approved for Bladder Cancerѻý> Combination reduced risk of death by 22% Mar 07, 2024
<ѻý>10,000 Steps Lowers Death Risk; Obesity Drug Beats Wegovy; Lead in Cinnamon Warningѻý> Health news and commentary from around the Web gathered by ѻý staff Mar 07, 2024
<ѻý>FDA Clears First OTC Continuous Glucose Monitorѻý> Dexcom's Stelo system available without a prescription by the summer Mar 06, 2024
<ѻý>FDA OKs First Interchangeable Biosimilars for Denosumabѻý> New products will carry all the same indications as Prolia and Xgeva, though launch date unclear Mar 06, 2024
<ѻý>FDA Says Eating Yogurt May Reduce Diabetes Riskѻý> Products will be allowed to carry claims as long as they don't mislead consumers Mar 04, 2024
<ѻý>Zyn Nicotine Pouches Are All Over TikTok, Sparking Debateѻý> Experts wrestle with their potential benefits and risks Mar 04, 2024
<ѻý>FDA OKs Amivantamab as First-Line Lung Cancer Treatmentѻý> Bispecific drug lands full approval for NSCLCs with EGFR exon 20 insertion mutations Mar 04, 2024